Latest News

Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs go »

 
Trillium Therapeutics Inc. (TTI) is a private research and development company. Our goal is to develop therapies that restore balance to the immune system in conditions associated with abnormal and harmful immune responses.